Author: digi

Case Studies: Drug Withdrawals Based on Phase 4 Clinical Trial Data

June 18, 2025

Case Studies: Drug Withdrawals Based on Phase 4 Clinical Trial Data How Phase 4 Clinical Trials Have Led to Drug Withdrawals: Key Case Studies and Lessons Learned Introduction While Phase 1–3 clinical trials are essential for regulatory approval, they often take place in controlled environments with limited patient diversity and short follow-up periods. Once a…

Phase 4 (Post-Marketing Surveillance)

Digital Marketing Strategies for Effective Patient Outreach in Clinical Trials

June 18, 2025

digi

How to Use Digital Marketing Strategies for Patient Outreach in Clinical Trials As traditional recruitment methods become less effective and more expensive, digital marketing is transforming how clinical trials reach and engage potential participants. Through targeted advertising, SEO, and social media campaigns, trial sponsors and CROs can connect with more diverse, qualified patients. This tutorial…

Clinical Research Operations, Patient Enrollment Strategies

Use of Single-Arm Trials in Rare Diseases – Clinical Trial Design and Protocol Development

June 18, 2025

digi

Use of Single-Arm Trials in Rare Diseases – Clinical Trial Design and Protocol Development “Implementing Single-Arm Trials for Rare Disease Treatment” Introduction The complexities of conducting clinical trials in rare diseases are numerous, including small patient populations, heterogeneity of disease presentation, and a lack of existing treatment options. One approach that has gained traction in…

Clinical Trial Design and Protocol Development, Single-Arm Trials

Scientific Terms in Phase 1 Clinical Trials: Definitions and Explanations

June 18, 2025

digi

Scientific Terms in Phase 1 Clinical Trials: Definitions and Explanations Scientific Terms in Phase 1 Clinical Trials: Definitions and Explanations Introduction Phase 1 clinical trials are foundational to drug development. They are rich with specialized terminology spanning pharmacokinetics, safety monitoring, statistics, and regulatory science. This glossary provides concise definitions of scientific terms and acronyms commonly…

Phase 1 (Safety and Dosage)

Best Practices for SDV in Electronic Medical Record (EMR) Systems

June 18, 2025

digi

How to Conduct Source Data Verification (SDV) in EMR Systems: A Step-by-Step Guide With the growing digitization of clinical data, most investigational sites have transitioned from paper-based records to Electronic Medical Record (EMR) systems. This transformation improves data accessibility but also introduces new complexities for monitors conducting Source Data Verification (SDV). CRAs (Clinical Research Associates)…

Site Management and Monitoring, Source Data Verification

Therapeutic Expertise of Boutique CROs

June 18, 2025

digi

Therapeutic Expertise of Boutique CROs Harnessing Therapeutic Expertise of Boutique CROs for Specialized Clinical Trials In the clinical research ecosystem, therapeutic expertise is not just a differentiator—it’s a strategic asset. Boutique Contract Research Organizations (CROs), known for their niche capabilities and focused approach, deliver unmatched value by offering deep therapeutic knowledge. These CROs often specialize…

Contract Research Organizations (CROs), Niche/Specialty CROs

Common Ethics Committee Submission Mistakes and How to Avoid Them

June 18, 2025

digi

Common Ethics Committee Submission Mistakes and How to Avoid Them Common Ethics Committee Submission Mistakes and How to Avoid Them Submitting to an Ethics Committee (EC) or Institutional Review Board (IRB) is a critical step in initiating any clinical trial. However, many submissions are delayed or rejected due to avoidable errors. These mistakes not only…

Ethics Committee Submissions, Informed Consent and Ethics Committees

Supply Chain Considerations for Home-Based Dosing in Decentralized Clinical Trials

June 18, 2025

digi

Supply Chain Considerations for Home-Based Dosing in Decentralized Clinical Trials Managing Supply Chain for Home-Based Dosing in Decentralized Clinical Trials Home-based dosing is a pivotal component of Decentralized Clinical Trials (DCTs), offering convenience to participants and expanding access to remote populations. However, delivering Investigational Medicinal Products (IMPs) to patients’ homes introduces significant logistical and regulatory…

Decentralized Clinical Trials (DCTs), Home Health Visits

Historical Control Data in Single-Arm Designs – Clinical Trial Design and Protocol Development

June 18, 2025

digi

Historical Control Data in Single-Arm Designs – Clinical Trial Design and Protocol Development “Data Control History in Single-Arm Design Studies” Introduction to Historical Control Data in Single-Arm Designs Historical control data is a type of analysis that utilizes previously collected data as a control group in a clinical study. This approach is frequently employed in…

Clinical Trial Design and Protocol Development, Single-Arm Trials

Virtual Assistants and Chatbots in Patient Support for Clinical Trials

June 18, 2025

digi

Virtual Assistants and Chatbots in Patient Support for Clinical Trials Leveraging Virtual Assistants and Chatbots to Support Clinical Trial Participants Clinical trials demand active and sustained engagement from participants, but study complexity and limited staff availability often hinder consistent support. To bridge this gap, virtual assistants and AI-powered chatbots are increasingly used to deliver real-time…

Patient Engagement Tools, Patient Recruitment and Retention